Graney & King LLC bought a new stake in MetLife, Inc. (NYSE:MET – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 421 shares of the financial services provider’s stock, valued at approximately $34,000.
Other hedge funds have also modified their holdings of the company. United Asset Strategies Inc. raised its stake in shares of MetLife by 1.1% during the fourth quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider’s stock valued at $895,000 after purchasing an additional 120 shares during the period. Barrett & Company Inc. increased its stake in MetLife by 1.0% during the 4th quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider’s stock worth $978,000 after buying an additional 121 shares during the period. J.W. Cole Advisors Inc. lifted its holdings in MetLife by 2.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 6,044 shares of the financial services provider’s stock worth $495,000 after buying an additional 126 shares in the last quarter. Davis R M Inc. boosted its position in MetLife by 4.2% in the 4th quarter. Davis R M Inc. now owns 3,148 shares of the financial services provider’s stock valued at $258,000 after buying an additional 127 shares during the last quarter. Finally, Avestar Capital LLC grew its stake in shares of MetLife by 3.2% during the third quarter. Avestar Capital LLC now owns 4,264 shares of the financial services provider’s stock valued at $352,000 after acquiring an additional 133 shares in the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Stock Performance
Shares of MET stock opened at $83.91 on Thursday. The company has a market cap of $57.16 billion, a P/E ratio of 14.05, a PEG ratio of 0.65 and a beta of 1.04. The business has a 50 day moving average of $83.50 and a two-hundred day moving average of $82.80. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th were issued a $0.545 dividend. The ex-dividend date was Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.60%. MetLife’s dividend payout ratio (DPR) is presently 36.52%.
Wall Street Analyst Weigh In
A number of research analysts recently commented on MET shares. JPMorgan Chase & Co. increased their price target on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Cowen reissued a “buy” rating on shares of MetLife in a research report on Friday, March 7th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Barclays decreased their price objective on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Finally, Keefe, Bruyette & Woods cut their target price on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 12th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $94.58.
Check Out Our Latest Research Report on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Energy Transfer: Powering Data With Dividends and Diversification
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Qualcomm Stock Is Coiling for a Breakout
- Manufacturing Stocks Investing
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.